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Heparin is an anticoagulant agent known to have diverse effects on angiogenesis with some reports suggesting
that it can induce angiogenesis while a few have indicated of its inhibitory property. Cancer patients treated for
venous thromboembolism with low molecular heparin had a better survival than the unfractionated heparin (UFH).
Heparin is known to interact with various angiogenic growth factors based on its sulfation modifications within the
glycosaminoglycan chains. Therefore it is important to study the mechanism of action of heparin of different
molecular weight to understand its angiogenic property. In this concern, we examined the angiogenic response of
higher molecular weight Heparin (15 kDa) of different concentrations using late CAM assay. Growth of blood
vessels in terms of their length and size was measured and thickness of the CAM was calculated morphometrically.
The observed increase in the thickness of the CAM is suggestive of the formation of capillary like structures at the
treated region. Analysis of the diffusion pattern showed internalized action of heparin that could affect gene
expression leading to proliferation of endothelial cells. Angiogenesis refers to formation of new blood vessels from
the existing ones and occurrence of new blood vessels at the treated area strongly confirms that heparin of 15 kDa
molecular weight has the ability to induce angiogenesis on CAM vascular bed in a dose dependent manner. The
results demonstrate the affinity of heparin to induce angiogenesis and provide a novel mechanism by which
heparin could be used in therapeutics such as in wound healing process.
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Heparin, a member of the glycosaminoglycan family of
carbohydrates found on the cell surface and in the extra-
cellular matrix [1] has the potential to induce angiogenesis
[2,3]. It was shown to bind both with angiogenic [4] and
anti-angiogenic proteins favoring and stabilizing the asso-
ciation with their respective receptors [5]. Heparin present
at the basal site of blood vessels act as matrix receptors by
interacting with a variety of basement membrane proteins
and is involved in the binding and internalization of lipo-
protein lipase on endothelium [6]. Heparin present in the
extra cellular matrix (ECM) may act as a reservoir for
angiogenic growth factors and will sustain the long-term
stimulation of endothelial cells [7]. It was already shown
that heparin of different molecular weight could promote
angiogenesis [8] on the chorioallantoic membrane of the
chick embryo and introduction of heparin directly into the* Correspondence: r_malathi@hotmail.com
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reproduction in any medium, provided the orallantoic sac of CAM [9] resulted in dilated sinuous arter-
ial and venous branches suggesting that heparin could in-
duce new blood vessel formation. Poly-l-lysine/heparin
complexes were found to stimulate angiogenesis in chick
embryo chorioallantoic membrane [10].
We analyzed the angiogenic effect of Heparin (15 kDa)
by treating CAM with 3 different concentrations (50, 100
and 150 μM) using gelatin sponges after 72hours of incu-
bation. Biotinylated Heparin contains 5–8 mole-percent
biotin and is attached through a 12-atom spacer arm con-
taining a cleavable disulfide group. This has been used
mainly to study its localization on CAM using streptavidin
labeled with HRP.
Diffusion of Heparin through various layers of CAM
and also the morphological changes induced on CAM
during treatment was analysed. Thickness of the CAM
was also measured to further substantiate the angiogenic
response and formation of new blood vessels. Angioquant
software was used to measure the growth of the vessels by
modifying the macroscopic images taken during treatmenttd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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angiogenesis using in vitro assays and has been employed
for CAM with some modifications. The results obtained
using morphometry and immunostaining of 15 kDa hep-
arin might be of therapeutic significance in angiogenic dis-
orders that requires neovascularisation.
Materials and Methods
Materials
Fertilized White leghorn chicken eggs (gallus gallus) were
purchased from, Tamil Nadu Poultry Research Station,
Madras Veterinary University, Nandanam, Chennai, India.
Gelatin sponges were from Jhonson & Jhonson Pvt Ltd,
Heparin from CALBIOCHEM, USA (Product No. 375054),
HRP conjugated streptavidin (HRP-anti-rabbit secondary)
from Bangalore Genei, India, Phosphate buffered solution
and other common reagents were purchased from Sigma,
Aldrich, USA.
Methods
The in ovo CAM model
Fertilized chicken eggs weighing 50± 2gm were incubated
at 37°C in a humidified atmosphere (>60% relative hu-
midity) based on protocol for the Hen's Egg Test-
Chorioallantoic Membrane (HET-CAM) method. At day
3 of post incubation, 2 to3 ml of albumin was withdrawn,
using a 21-gauge needle, through the large blunt edge of
the egg in order to minimize adhesion of the shell mem-
brane with CAM. A square window of 1 cm² was opened
in the egg shell and sealed with paraffin film to prevent
dehydration and the eggs were returned for incubation.
On day 9th, gelatin sponges of size of 1 mm³ were placed
on the top of growing CAM under sterile condition [11].
The sponges were soaked with 10 μl of 50, 100 and
150 μM concentrations of heparin. Control CAM was
treated with 10 μl of 1X PBS. The window was closed with
a transparent adhesive tape and the eggs were returned
for further incubation till day 12 (72hours) at which
vascularization potential of the CAM reaches its max-
imum. The experimental groups were divided into 4 with
each containing 40 numbers. Group1 represents 1X PBS
(control), group 2, 3 and 4 corresponds to 10 μl of 50 μM,
100 μM and 150 μM of heparin. Treated CAM was photo-
graphed at 0, 24, 48 and 72hours using Cannon digital
camera and the images were analyzed with Angioquant
Toolbox, MATLAB 6.5 software to measure total length
and size of blood vessels in micrometer at the area of
treatment [12–14].
Histology
CAM treated with heparin was flooded with Bouin's
fixative solution and the treated area was removed,
dehydrated and embedded in paraffin wax. Vertical cross
sections of 7 μm in thickness were taken using RotaryMicrotome (Weswicox, Japan) [15]. The histological sec-
tions were observed under Light Microscope at 40X
magnification for qualitative assessment and images
were taken using Nikon Camera attached with light
microscope at 10X magnification.
Morphometric analysis
Thickness of the CAM was measured from haematoxy-
lin and eosin stained sections with a calibrated objective
at 40X magnification using 10X10 calibrated grids in the
10X ocular. Each CAM was measured at 6 different
locations from 6 serial cross sections of the same sam-
ple. To calculate mean tissue thickness (DCAM) all of
the representative sections from the particular tissue
sample were measured in micrometer and averaged to
yield a mean CAM thickness [15].
Immunohistochemical analysis
Sections of CAM of 7 μM thickness were obtained using
microtome after treatment with heparin. After 12hours
of incubation at 37°C the sections were dewaxed. Sec-
tions were washed with 1X PBS and incubated with HRP
conjugated streptavidin (HRP-anti-rabbit secondary) of
1:40 dilution for 1 hour at 37°C. After counterstaining
with haematoxylin and eosin dehydration was performed
with alcohol. Images were recorded after mounting with
90% of glycerol using Nikon camera attached with light
microscope at 40X magnification. Immunohistochemical
staining was performed on paraffin-embedded tissue sec-
tions with slight modifications.
Data analysis and statistics
All the experiments were performed in triplicate (n=3) un-
less otherwise specified. Data are presented as mean±SEM
and were analyzed by One-Way ANOVA analysis of vari-
ance test, Student’s t-test and Tukey post hoc tests as
appropriate by Sigma Stat 2.0. p=< 0.001 and p=0.001
were considered as statistically significant.
Results
Visualization of blood vessels on CAM
We studied the role of heparin in the angiogenic process by
performing a CAM assay. An increase in the number
of blood vessels was observed for all 3 concentrations
(50,100,150 μM) of heparin at 72hours of treatment.
Among three concentrations 100 μM heparin showed
distinct spoke wheel pattern of vessels with numerous al-
lantoic vessels around the gelatin sponge demonstrating the
angiogenic potential of heparin while control CAM treated
with PBS showed slow and steady growth of allantoic ves-
sels (Figure 1a). The observation is also supported by the
skeletonized prune images obtained from Angioquant
software (Figure 1a). Angiogenic potential of heparin was
further analysed by measuring the growth of the vessels
Figure 1 a. Effect of biotin conjugated heparin on late CAM. Images of late CAM treated with 50, 100 and 150 μM heparin. Control CAM was
treated with 1X PBS. CAM treated with 100 μM heparin shows increased vascularization around the sponge as spoke wheel pattern which is
comparatively higher than other concentrations and is also supported by skeletonized prune images by Angioquant software. Images are taken
using Canon digital camera at 4X magnification and are the result of 3 different set of experiments. Arrow indicates the presence of blood
vessels. 1b. Effect of biotin conjugated heparin on the growth of blood vessels on late CAM. Total length and size of the blood vessels was
measured using Angioquant software after treating CAM with 50, 100 and 150 μM heparin. Control CAM was treated with 1X PBS. Images
recorded at 0, 24, 48 and 72hours were analyzed individually. Values at 0hour were taken as one for all. CAM treated with 100 and 150 μM
heparin shows significant increase in vessels length (graph a) and size (graph b) after 72hours of treatment when compared to control. Though
both the concentrations shows significant changes, 100 μM heparin shows comparatively higher angiogenic potential. Experiments were
performed in triplicate and data presented as mean± SEM, #p = 0.001 and *p =<0.001 versus control.
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ous time points of incubation namely at 24, 48 and 72hours
of treatment (Figure 1b). A significant increase in the vessel
length (#p=0.001) and size (*p=<0.001) was observed on
CAM treated with 100 and 150 μM concentrations of
heparin with 100 μM exhibiting maximum angiogenic
response.
Qualitative assessment of angiogenic potential
We further demonstrated the angiogenic potential of hep-
arin by studying the morphological features of CAM after
treatment (Figure 2). CAM treated with PBS showed uni-
form tissue thickness without any bulging appearance.
Large blood vessel was seen without the appearance of
sprouts. The histological appearance was same throughout
the chorionic and allantoic epithelial layers. CAM treated
with 100 μM heparin showed increased thickness at the
thin stratum due to altered fibroblast, epithelial and endo-
thelial cellular morphology. Large numbers of elongated
ECs were visible with sprouting appearance. The thicknessof the primary stratum also increased due to accumulation
of fibroblast at sub-epithelial capillary network (SEC) giv-
ing an irregular appearance. Very small capillaries were
visible at the connective tissue area due to occasional
sprouting from pre existing vessels which tends to pass to
the chorionic sinus and could be concluded as the sprout-
ing angiogenic effect at this particular concentration.
CAM treated with 50 μM and 150 μM heparin showed ir-
regular appearance of thin stratum at chorionic epithelial
layer due to stratification of the cells mainly by fibroblast
cells at SEC. A few small capillaries were also visible for
150 μm but radial pattern of fibroblast was reiterated.
Measurement of CAM thickness (DCAM)
Growth of the vessels was further confirmed by measur-
ing the thickness of CAM from paraffin embedded verti-
cal sections and plotted as shown in Figure 3. In
paraffin-embedded tissue, material shrinkage could be
estimated to be ~25% relative to the fresh material and
can be assumed to be the same since all tissues were
Figure 3 Thickness of CAM treated with heparin. Total thickness
of the tissue at the area of treatment was measured from
haematoxylin and eosin stained paraffin embedded CAM tissues and
plotted. Thickness of the CAM treated with heparin is higher than
that of control CAM for 72hours. CAM treated with 100 μM heparin
showed a significant increase in tissue thickness when compared
with the other concentrations.Each value is expressed as
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Figure 2 Effect of heparin on CAM morphology. (a) CAM treated
with 1X PBS shows thin chorionic (ce) and allantoic (ae) epithelial
layer due to minimal accumulation of fibroblast cells (fb) with
subepithelial capillary network (SEC) along with the presence of
large blood vessels (lbv) and vein (v). (b) CAM treated with 50 μM
heparin shows increased thickness at ce and ae due to fb
accumulation along with the presence of small blood vessels (sbv)
at stroma region. (c) CAM treated with 100 μM heparin shows
increased thickness at the ae and ce due to increased accumulation
of fb with densely packed small blood vessels beneath SEC and also
ECs capillary sprouting as small sprouting vessels (sv) which
extending towards SEC. Presence of numerous small capillaries (sc)
and lbv along with v are also visible at the stroma region. (d)150 μM
heparin shows diminished fibroblast accumulation at thin stratum
and also reiteration of radial arrangement of fb, lbv and sbv are also
visible with minimal sprouting of sc. Gelatin sponges did not cause
wound or inflammation. Representative tissues are 7 μm in thickness
stained with haematoxylin and eosin and images were taken at 40X
magnification and are the result of 3 different set of experiments.
Bar is 50 μm.
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not necessary for comparisons of tissue thickness. CAM
treated with 100 μM heparin showed significant increase
(*p = <0.001) in tissue thickness when compared to the
values obtained for 50 μM and 150 μM concentrations.
Diffusion pattern of heparin
Diffusion of biotin conjugated heparin through various
membranes of CAM was analyzed based on its binding
with streptavidin. The presence of biotin-strepatavidin
complexes is indicative of the diffusion of heparin (Figure 4)
through the membrane and the intensity increased with in-
crease in the concentrations. CAM treated with 50 μM
heparin showed that it had diffused through the chorionic
and sub epithelial cell layers and could favor the activationof fibroblast cell. CAM treated with 100 μM heparin
showed that the diffusion occurred not only at the chori-
onic and sub epithelial layer but also at the stroma in
which are present the capillary plexes/blood sinus. This
could favor endothelial cell migration which is considered
to be the most important step in angiogenesis. CAM trea-
ted with 150 μM heparin showed that the diffusion is
greater at the sub epithelial layer and in stroma region sug-
gesting that heparin (15 KDA) could favor angiogenesis.
Discussion
The present study reveals the mechanisms by which
heparin of 15 kDa can induce angiogenesis in vitro. New
blood vessel formation and its growth on CAM treated
with heparin of varying concentrations implied that it
has the potential to induce sprouting angiogenesis as
observed in the increase in vessel length and size. The
usage of Angioquant software to measure vessel growth
in vivo is already reported by others. In sprouting angio-
genesis activated Endothelial cells (ECs) favor binding of
growth factors such as Vascular Endothelial Growth Factor
(VEGF) and basic Fibroblast Growth Factor 2 (FGF2) with
its specific receptors which could be activated by various
external and internal stimulus [17] resulting in the degrad-
ation of extra cellular matrix by Matrix Metalloproteases
(MMPs) and proliferation of ECs to form immature blood
vessels [18]. These immature blood vessels are further sta-
bilized by the recruitment of mural cells which can con-
tribute to the increase in the size of the vessels [19]. It is
understood that heparin could interact with these angio-
genic growth factors [20,21] and act as a mitogen for
capillary ECs both in vivo [22] and in vitro [23]. Thus it
could be concluded that heparin could induce sprouting
Figure 4 Diffusion pattern of heparin through various layer of CAM. CAM treated 1X PBS doesn’t show any diffusion pattern (a) stained
without HRP and (b) with HRP. CAM treated with 50 μM heparin shows diffusion at chorionic (ce) and sub epithelial layers (c) stained without
HRP and (d) with HRP. CAM treated with 100 μM heparin shows diffusion at ce and sub epithelial layers and also at stroma region (e) stained
without HRP and (f) with HRP. CAM treated with 150 μM heparin shows higher intensity of HRP staining due to higher concentration and shows
diffusion pattern at ce and sub epithelial layers and also at stroma region (g) stained without HRP and (h) with HRP. Arrow indicates the presence
of biotin-streptavidin complex. Magnification for a, c, e and g is 10X and for b, d, f and h is 40X and are the results of 3 different set of
experiments. For a, c, e and g bar is 50 μm and for b, d, f and h bar is 100 μm.
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different time points showed that its action is dose-
dependent with maximum efficacy at 100 μM after 72
hours of treatment.
It was proved that histology of the CAM changes as a
response towards the biological materials placed on it inc-
luding EC migration [24], fibroblast and mast cell accu-
mulation [25,26], changes in thickness of the epitheliallayer, increase in the number of capillaries and capillary
cords formation [15], presence of apoptotic ECs [27–30].
In the present study heparin is found to alter the morph-
ology of those cells which have a direct role in angiogen-
esis similar to that reported earlier [15]. The histological
changes associated with 100 μM is suggestive of favo-
ring blood vessel formation stronger than other two
concentrations.
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between chorionic and allantoic layers (in micrometer) that
contains different kind of cells and any morphological
change found in these cells could affect the entire struc-
ture of the CAM. An earlier study showed that angiogenic
activity of the substance could be measured by calculating
cell density of fibroblast, ECs and epithelial cells [15,31].
Thickness of the CAM increases gradually during the early
and mid phase of embryo growth due to the capillary migra-
tion from stroma region towards the inner shell membrane
(ISM) [32]. The ISM lies very close to the basal lamina
which is the outer surface of the CAM where gelatin
sponges soaked with heparin are implanted. The thickness
of CAM treated with heparin had increased indicating the
proliferation and growth of the blood vessels and can be
concluded that heparin has the potential to induce new ves-
sels formation with maximum performance at 100 μM con-
centration within 72hours.
It is already known that the angiogenic response of
CAM depends on diffusion of test materials through the
CAM thereby indicating its involvement in angiogenesis.
We studied the diffusion pattern of biotinylated heparin
and found that heparin had diffused through various layers
of CAM. The affinity of biotin with streptavidin has made
it useful for numerous bioanalytical and biotechnological
applications [33–35] using CAM and mouse embryo assays
[36]. The diffusion pattern showed internalized action of
heparin that could affect gene expression on endothelial
cell and could stabilize, potentiate and transport growth
factors which favor angiogenesis. This diffusion pattern
was found to depend on the concentrations and implied
the fact that though the higher concentration (150 μM)
could favor new blood vessel formation up to certain ex-
tent might cause cellular damage. The diffusion of 100 μM
heparin to the stroma region indicates that it would have a
direct impact on angiogenesis and can favor sprouting of
blood vessels.Conclusion
The present study evaluates the effects of HMWH on for-
mation of capillary-like tubular structures using CAM
assay. UFH of 15 kDa enhances its formation in contrast to
LMWH which is known to decrease the formation of tubu-
lar endothelial structures. Thus the present in ovo vivo
study has demonstrated that heparin possesses the angio-
genesis inducing affinity and is significant at 100 μM con-
centration. These data provide a novel mechanism by
which higher molecular weight heparins can promote for-
mation of capillary-like tubular structures and might be of
therapeutic significance in inducing angiogenisis during
wound healing process while the low molecular weight
constituents can be employed to inhibit angiogenesis as in
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